Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Pulmatrix (PULM) Q2 Revenue Falls 100%Photo, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Pulmatrix (PULM) Q2 Revenue Falls 100%

Pulmatrix (NASDAQ:PULM), a biotechnology company known for its dry powder inhalation delivery platform iSPERSE™, released its second quarter results on August 6, 2025, covering the quarter that

F&g Annuities (FG) Q2 Revenue Up 16%Photo, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
F&g Annuities (FG) Q2 Revenue Up 16%

F&g Annuities & Life (NYSE:FG), a major provider of annuities and life insurance serving both retail and institutional clients, reported its financial results for the second quarter of fiscal 2025

Gladstone (GOOD) Q2 Revenue Rises 5%
Gladstone (GOOD) Q2 Revenue Rises 5%

Gladstone Commercial (NASDAQ:GOOD), a real estate investment trust (REIT) focused on single-tenant industrial and office properties, reported its second quarter 2025 results on August 6, 2025. The

TransAct (TACT) Q2 Revenue Jumps 19%Photo, wide shot, wide-angle lens,  Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png
TransAct (TACT) Q2 Revenue Jumps 19%

TransAct Technologies (NASDAQ:TACT), a technology supplier focused on printing and software equipment for the food service and gaming industries, released second-quarter 2025 earnings on August 6

Openlane (KAR) Q2 Revenue Jumps 9%
Openlane (KAR) Q2 Revenue Jumps 9%

Openlane (NYSE:KAR), a leading digital marketplace operator for wholesale used vehicles, reported its second quarter 2025 earnings on August 6, 2025. The most notable news from the release was a

OppFi (OPFI) Q2 Revenue Jumps 13%
OppFi (OPFI) Q2 Revenue Jumps 13%

OppFi (NYSE:OPFI), a digital lending platform focused on serving consumers who are underserved by traditional financial institutions, reported its second-quarter 2025 financial results on August 6

Adma Biologics (ADMA) Q2 Revenue Up 14%
Adma Biologics (ADMA) Q2 Revenue Up 14%

Adma Biologics (NASDAQ:ADMA), a plasma-derived biologics manufacturer focused on immunotherapies, released its earnings for Q2 2025 on August 6, 2025. The quarter showed continued revenue growth

Seres (MCRB) Q2 Loss Narrows 34%Photo, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Seres (MCRB) Q2 Loss Narrows 34%

Seres Therapeutics (NASDAQ:MCRB), a clinical-stage biotech focused on microbiome therapeutics, released its second quarter 2025 earnings on August 6, 2025. The main highlight was a narrowing net

Artiva (ARTV) Q2 Loss Widens 19.7%Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Artiva (ARTV) Q2 Loss Widens 19.7%

Artiva Biotherapeutics (NASDAQ:ARTV), a clinical-stage biotechnology company pioneering allogeneic natural killer (NK) cell therapies for autoimmune diseases, released its financial results for the

Brookdale (BKD) Q2 Revenue Rises 4.6%Photo, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png
Brookdale (BKD) Q2 Revenue Rises 4.6%

Brookdale Senior Living (NYSE:BKD), the nationwide operator of senior living communities, released its results for Q2 2025 on August 6, 2025. The period saw a notable jump in occupancy and stronger

Certara (CERT) Q2 Revenue Jumps 12%
Certara (CERT) Q2 Revenue Jumps 12%

Certara (NASDAQ:CERT), a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue

Upstream Bio (UPB) Q2 R&D Soars 169%Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Upstream Bio (UPB) Q2 R&D Soars 169%

Upstream Bio (NASDAQ:UPB), a biotechnology company developing new therapies for respiratory diseases, released its second quarter 2025 results on August 6, 2025. The main headline was rapid

CRH (CRH) Q2 Revenue Rises 6%
CRH (CRH) Q2 Revenue Rises 6%

CRH (NYSE:CRH), the global building materials firm, reported its earnings release for the second quarter of fiscal 2025 on August 6, 2025. The company delivered GAAP revenue of $10.2 billion and

Boeing Defense Workers Just Went on Strike. Should Investors Be Concerned?Photo, wide shot, wide-angle lens,  Construction equipment, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/96af5505-e3c8-4496-bbb7-e4a5eba91e77.png
Boeing Defense Workers Just Went on Strike. Should Investors Be Concerned?

More than 3,200 Boeing (NYSE: BA) workers at the company's St. Louis-area defense factories went on strike Monday after the International Association of Machinists and Aerospace Workers (the IAM

Inspired (INSE) Q2 Revenue Jumps 7%
Inspired (INSE) Q2 Revenue Jumps 7%

Inspired Entertainment (NASDAQ:INSE), a gaming technology provider covering casino systems, virtual sports, and interactive gaming content, released its results on August 6, 2025. The business

AnaptysBio (ANAB) Q2 Revenue Jumps 103%Photo, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
AnaptysBio (ANAB) Q2 Revenue Jumps 103%

AnaptysBio (NASDAQ:ANAB), a clinical-stage biotechnology company focused on innovative immunology therapeutics for autoimmune and inflammatory diseases, released its Q2 2025 earnings on August 6

Pyxus (PYYX) Q1 Revenue Falls 20%
Pyxus (PYYX) Q1 Revenue Falls 20%

Pyxus International (OTC:PYYX), a global leaf tobacco merchant and supply chain manager, released its first-quarter fiscal 2026 results on August 6, 2025. Revenue (GAAP) for Q1 FY2026 was $508.8

Paycom (PAYC) Q2 Revenue Rises 10.5%
Paycom (PAYC) Q2 Revenue Rises 10.5%

Paycom (NYSE:PAYC), a leading provider of cloud-based human capital management (HCM) software, reported second quarter 2025 results on August 6, 2025. The company posted GAAP revenue of $483.6

Royalty Pharma (RPRX) Q2 Receipts Up 20%Photo, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Royalty Pharma (RPRX) Q2 Receipts Up 20%

Royalty Pharma Plc (NASDAQ:RPRX), a leader in acquiring royalties on biopharmaceutical products, released second quarter results on August 6, 2025. The most notable news: Royalty Receipts—its

Dayforce (DAY) Q2 EPS Jumps 27%Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
Dayforce (DAY) Q2 EPS Jumps 27%

Dayforce (NYSE:DAY), a global provider of human capital management (HCM) software, released its second-quarter 2025 earnings on August 6, 2025. The company reported notable earnings and revenue

EverCommerce (EVCM) Q2 Revenue Up 5%Photo, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
EverCommerce (EVCM) Q2 Revenue Up 5%

EverCommerce (NASDAQ:EVCM), a software firm specializing in digital solutions for service-based small and medium-sized businesses (SMBs), released its results for Q2 2025 on August 6, 2025. The

Procept (PRCT) Q2 Revenue Jumps 48%Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Procept (PRCT) Q2 Revenue Jumps 48%

Procept BioRobotics (NASDAQ:PRCT), a medical technology company specializing in robotic surgical systems for benign prostatic hyperplasia (BPH) treatment, posted second-quarter 2025 results on

Verra Mobility (VRRM) Q2 Revenue Up 6%
Verra Mobility (VRRM) Q2 Revenue Up 6%

Verra Mobility (NASDAQ:VRRM), a leader in smart mobility technology serving commercial fleets and government agencies, released its second-quarter results on August 6, 2025. The headline news from

Zentalis (ZNTL) Q2 Loss Narrows 70%
Zentalis (ZNTL) Q2 Loss Narrows 70%

Zentalis Pharmaceuticals (NASDAQ:ZNTL), a clinical-stage biopharmaceutical company focused on developing cancer therapies, released its second quarter earnings on August 6, 2025. The headline news

Astec (ASTE) Q2 EPS Jumps 59%
Astec (ASTE) Q2 EPS Jumps 59%

Astec Industries (NASDAQ:ASTE), a leading manufacturer of equipment for road building and aggregate processing, reported results for Q2 2025 on August 6, 2025. In this report, the company delivered